Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,215.00    -16.00 (-1.30%)
Bid:
1,215.00
Ask:
1,248.00
Spread: 33.00 (2.716%)
Market Cap: £847.40m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Trading Update

23 Jul 2013 08:09

RNS Number : 9168J
CVS Group plc
23 July 2013
 

 

23 July 2013

 

CVS Group plc (the "Group")

 

Trading Update

 

The Board is pleased to announce that the results for the year ended 30 June 2013 will be in line with market expectations and will be released on Tuesday 24 September 2013.

 

Total like-for-like Group turnover for the year showed growth of 3.4%. This growth was achieved despite sales being moderately impacted by snow during January (0.2% impact) and there being one fewer trading days in the second half of 2013 compared to 2012 (0.3% impact).

 

Good organic growth has been achieved in the core veterinary practices throughout the year. The period has seen growth of over 70% in the membership of loyalty schemes which now exceed 111,900 pets compared to 65,500 at this time last year. At current run rates loyalty schemes are contributing over 9% of the total revenue from practices.

 

It is pleasing to report that there has been significant growth in the e-commerce operations. Animed Direct is currently generating some £6.7 million of annualised revenue, compared with £3.5 million at 30 June 2012 and continues to show significant growth opportunities. In addition, five on-line practice shops were opened during the year.

 

Internally funded acquisition activity has continued to play an important part in the Group's strategy. In addition to the three practices and the pet crematorium acquired in the first half of the year, four practices, Cranmore (two sites in Chester), Archway (Petersfield), Alver (three sites in and around Gosport) and Filham Park (Ivy Bridge, Devon) were acquired during the second half. These four acquisitions extend the Group's practice division's operations and the sites are an excellent geographic fit with the Group's existing surgeries. All of the acquisitions have been successfully integrated into the Group. Subsequent to the year end on 15 July 2013, Crescent (Melton Mowbray) was acquired. Based on the last financial year prior to acquisition the aggregate turnover derived from these five additional practices amounted to £8.3 million.

 

As well as small animal services, the Filham Park and Crescent practices both include some equine activities, extending our offering in this area. The Cranmore acquisition includes a referrals centre and on 1 July 2013 Professor John Innes joined us as a Referrals Director to run and expand our referrals business. John has been a leading figure in the academic and animal orthopaedic worlds for many years; most recently he has been closely involved in developing clinical services at the University of Liverpool. Not only will John bring world class experience in orthopaedics to the Group, but he will also bring experience and expertise in the development of referral services.

 

In total the Group now operates 248 veterinary practices across the UK, an on-line dispensary and 11 on-line practice shops, 5 diagnostic laboratories and 2 pet crematoria. CVS continues to be the UK's largest operator in a highly fragmented market.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer 020 7496 3000

Aubrey Powell

Graeme Summers

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGZNNFKGFZG
Date   Source Headline
19th Nov 20214:26 pmRNSHolding(s) in Company
10th Nov 202111:17 amRNSHolding(s) in Company
3rd Nov 20212:30 pmRNSPCA Shareholding
1st Nov 20218:00 amRNSHolding(s) in Company
29th Oct 202110:17 amRNSPosting of Annual Report & Notice of AGM
29th Oct 20217:00 amRNSExercise of Options and Total Voting Rights
13th Oct 20216:01 pmRNSExercise of Options, PDMR Dealing and TVR
7th Oct 20211:52 pmRNSHolding(s) in Company
7th Oct 20217:00 amRNSLong Term Incentive Plan Awards & PDMR Dealing
30th Sep 20217:00 amRNSExercise of Options and Total Voting Rights
29th Sep 20215:28 pmRNSHolding(s) in Company
28th Sep 20217:54 amRNSHolding(s) in Company
23rd Sep 20217:00 amRNSBoard Changes
23rd Sep 20217:00 amRNSFinal results for the year ended 30 June 2021
13th Sep 20211:50 pmRNSHolding(s) in Company
31st Aug 20217:00 amRNSExercise of Options and Total Voting Rights
27th Aug 20215:34 pmRNSHolding(s) in Company
26th Aug 20218:48 amRNSBlock Listing Application
24th Aug 20214:10 pmRNSHolding(s) in Company
20th Aug 20212:09 pmRNSHolding(s) in Company
20th Aug 20212:07 pmRNSHolding(s) in Company
30th Jul 202112:00 pmRNSExercise of Options and Total Voting Rights
29th Jul 20214:14 pmRNSHolding(s) in Company
20th Jul 20217:00 amRNSTrading Update
13th Jul 202112:40 pmRNSBlock Listing Interim Review and TVR Update
30th Jun 20217:00 amRNSExercise of Options and Total Voting Rights
28th May 202112:00 pmRNSExercise of Options and Total Voting Rights
13th May 20218:30 amRNSShareholder Consultation regarding 2020 AGM
30th Apr 202112:00 pmRNSExercise of Options and Total Voting Rights
30th Apr 20217:00 amRNSTrading Update
7th Apr 20217:00 amRNSDirector/PDMR Shareholding
31st Mar 20217:00 amRNSExercise of Options and Total Voting Rights
30th Mar 20219:06 amRNSDirector/PDMR and PCA Shareholding
25th Mar 20217:00 amRNSInterim Results
3rd Mar 20217:30 amRNSHolding(s) in Company
26th Feb 202112:00 pmRNSExercise of Options and Total Voting Rights
5th Feb 20214:30 pmRNSHolding(s) in Company
29th Jan 202112:00 pmRNSExercise of Options
29th Jan 20217:00 amRNSTrading Update
6th Jan 20219:30 amRNSBlock Listing Application
5th Jan 20217:00 amRNSLong Term Incentive Plan Award
31st Dec 20207:00 amRNSExercise of Options
4th Dec 20209:34 amRNSGrant of Options under SAYE Scheme & PDMR Dealing
26th Nov 20203:49 pmRNSResult of AGM
26th Nov 20207:00 amRNSAGM Statement and Trading Update
23rd Nov 20207:00 amRNSHolding(s) in Company
9th Nov 20201:32 pmRNSLong Term Incentive Plan Awards & PDMR Dealing
6th Nov 20201:46 pmRNSHolding(s) in Company
4th Nov 20202:30 pmRNSPosting of Annual Report & Notice of AGM
30th Oct 20205:09 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.